Literature DB >> 16803494

Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study.

Q D Pieterse1, J B M Z Trimbos, A Dijkman, C L Creutzberg, K N Gaarenstroom, A A W Peters, G G Kenter.   

Abstract

The objective of this study was to assess the role of postoperative radiotherapy (RT) in early-stage cervical carcinoma with risk factors other than positive nodes, parametrial invasion, or positive margins and to compare outcomes using the Leiden University Medical Center (LUMC) modification of the Gynecologic Oncology Group (GOG) system with the GOG prognostic scoring system itself. Between January 1984 and April 2005, 402 patients with early-stage cervical cancer underwent radical hysterectomy. A total of 51 patients (13%) had two of the three risk factors and had pathologic tumor size (> or =40 mm), invasion (> or =15 mm), and capillary lymphatic space involvement, and were identified as the so-called high-risk (HR). We compared 34 patients who received RT based on the LUMC risk profile (67%) with 17 who did not (33%). The GOG score was calculated as well. We compared the GOG scores within the LUMC risk groups: HR+ (two out of three risk factors) and HR- (less than two out of three risk factors). Differences in 5-year cancer-specific survival (CSS) and 5-year disease-free survival (DFS) between the HR group treated with RT (86%, 85%) and without RT (57%; 43%) were statistically significant. The LUMC criteria did not significantly differ from the GOG risk profile, concerning recurrence, CSS, and DFS. HR patients benefit from adjuvant RT. The LUMC modification of the GOG system seems to be simpler and has a slightly higher threshold for the indication for RT but without a difference in outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16803494     DOI: 10.1111/j.1525-1438.2006.00600.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Long-term follow-up results of simultaneous integrated or late course accelerated boost with external beam radiotherapy to vaginal cuff for high risk cervical cancer patients after radical hysterectomy.

Authors:  Xin Wang; Yaqin Zhao; Yali Shen; Pei Shu; Zhiping Li; Sen Bai; Feng Xu
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

Review 2.  Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature.

Authors:  David Cibula; Nadeem R Abu-Rustum; Daniela Fischerova; Selvan Pather; Katie Lavigne; Jiri Slama; Kaled Alektiar; Lin Ming-Yin; Roman Kocian; Anna Germanova; Filip Frühauf; Lukas Dostalek; Ladislav Dusek; Kailash Narayan
Journal:  Gynecol Oncol       Date:  2018-10-20       Impact factor: 5.482

3.  Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.

Authors:  H van Meir; R A Nout; M J P Welters; N M Loof; M L de Kam; J J van Ham; S Samuels; G G Kenter; A F Cohen; C J M Melief; J Burggraaf; M I E van Poelgeest; S H van der Burg
Journal:  Oncoimmunology       Date:  2016-12-23       Impact factor: 8.110

4.  Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors.

Authors:  Hao Yu; Linlin Zhang; Xuelian Du; Xiugui Sheng
Journal:  Onco Targets Ther       Date:  2016-12-01       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.